EPAX NORWAY AS (Norway) holds 1 active US FDA Type II Drug Master File and 2 inactive. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “EPAX NORWAY AS: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/epax-norway-as

Overview

EPAX NORWAY AS is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering EPAX 4608 EE US PH (EPA-ENRICHED FATTY ACID ETHYL ESTER).

Core services & business areas

API Manufacturing

API / Drug Master Files

EPAX NORWAY AS holds 1 active (3 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • EPAX 4608 EE US PH (EPA-ENRICHED FATTY ACID ETHYL ESTER)Active2011-12-20
  • EPAX 5010 EE US PhInactive2018-06-26
  • EPAX 6015 TGN US APIInactive2013-07-22

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to EPAX NORWAY AS in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this EPAX NORWAY AS?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.